The number of people with susceptibility test result for rifampicin in Israel
Israel: The number of people with susceptibility test result for rifampicin was 103 in 2021. ▼ Falling
Latest (2021)
103
Change on year
up 15.7%
World rank
108th
of 155 countries
All-time high
154
in 2018
All-time low
89
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Israel, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Israel is 103, measured in 2021.
The figure is up 15.7% on the previous year and down 20.2% over five years.
That places Israel 108th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Israel, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 129 | — |
| 2018 | 154 | +19.4% |
| 2019 | 105 | -31.8% |
| 2020 | 89 | -15.2% |
| 2021 | 103 | +15.7% |
Israel compared with similar countries
- Israel's 103 is below the median for high income countries, which is 142, 73% of the median. (61 countries reporting)
- Israel's 103 is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 406, 25% of the median. (16 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 129.33 | 105 | 154 | 3 |
| 2020s | 96 | 89 | 103 | 2 |
Countries ranked near Israel
More health data for Israel
- Un projection of annual infant deaths, annual growth rate -1.65 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6956 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 665.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 119 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2022)
- Population ages 00-04, female, annual growth rate -0.3823 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0445 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3508 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Israel?
- The number of people with susceptibility test result for rifampicin in Israel was 103 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Israel?
- The highest recorded value was 154 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Israel?
- The lowest recorded value was 89 in 2020.
- How does Israel rank for the number of people with susceptibility test result for rifampicin?
- Israel ranks 108th out of 155 countries with data for 2021.
- Where does this Israel data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).